KLF2 and precursor B-cell acute lymphoblastic leukemia: Strikingly, we found that in the KLF2-low group of B-ALL patients, the percentage of leukemia cells in the bone marrow was significantly lower than in the KLF2-high group at disease diagnosis (p = 0.04) (Figure 3B).